4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
7.79
-0.20 (-2.50%)
At close: Nov 22, 2024, 4:00 PM
7.78
-0.01 (-0.13%)
After-hours: Nov 22, 2024, 6:13 PM EST
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $360.11 million as of November 22, 2024. Its market cap has decreased by -27.98% in one year.
Market Cap
360.11M
Enterprise Value
-165.72M
1-Year Change
-27.98%
Ranking
Category
Stock Price
$7.79
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $360.11M, a decrease of -37.95%. That is a compound annual growth rate of -11.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 388.78M | -55.12% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 403.73M |
| Larimar Therapeutics | 397.52M |
| Verve Therapeutics | 397.07M |
| Semler Scientific | 395.75M |
| Akebia Therapeutics | 394.91M |
| Revance Therapeutics | 393.38M |
| enGene Holdings | 390.99M |
| KalVista Pharmaceuticals | 389.59M |